Join PHEN meeting on January 19th at 6:00 PM EST with guest speaker Dr. Arthur Burnett of Johns Hopkins Medical School who will present on managing sexual health.
Prostate cancer clinical trials using Prostate-Specific-Membrane Antigen (PSMA) are ushering in a new generation of treatment therapies and diagnostic tools offering breakthrough benefits for patients.
PHEN Network member Barney Morris speaks about his prostate cancer journey at the American Society of Radiation Oncology (ASTRO) Annual Meeting.
Clinical trials are important treatment options all along your prostate cancer journey.
Dr. Keith Crawford presents clinical trial opportunities that are available and how to make them work for you.
Risk levels are determined by PSA Numbers, Biopsy Results, Gleason Scores, Grade Groups and Cancer Stage.